CD47 and colorectal cancer: Similar to what is seen in modulating PD-1 in colorectal cancer, inhibiting the CD47 checkpoint pathway has been shown to restore function of macrophages and thus led to growth inhibition and regression of tumor cells in experimental models (44, 45).